Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58


Identification and Functional Characterization of Long Non-coding RNA MIR22HG as a Tumor Suppressor for Hepatocellular Carcinoma.

Zhang DY, Zou XJ, Cao CH, Zhang T, Lei L, Qi XL, Liu L, Wu DH.

Theranostics. 2018 Jun 13;8(14):3751-3765. doi: 10.7150/thno.22493. eCollection 2018.


Reduced RNA-binding protein HuD in pancreatic neuroendocrine tumors lowers p27Kip1 levels linked to poor prognosis.

Kim C, Jeong DE, Heo S, Ji E, Rho JG, Jung M, Ahn S, Kim YJ, Kim YS, Nam SW, Kulkarni RN, Lee KB, Lee EK, Kim W.

J Pathol. 2018 Jul 17. doi: 10.1002/path.5135. [Epub ahead of print]


Cytoplasmic Hu-Antigen R (HuR) Expression is Associated with Poor Survival in Patients with Surgically Resected Cholangiocarcinoma Treated with Adjuvant Gemcitabine-Based Chemotherapy.

Toyota K, Murakami Y, Kondo N, Uemura K, Nakagawa N, Takahashi S, Sueda T.

Ann Surg Oncol. 2018 May;25(5):1202-1210. doi: 10.1245/s10434-018-6392-y. Epub 2018 Feb 28.


MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR).

Al-Haidari A, Algaber A, Madhi R, Syk I, Thorlacius H.

Cancer Lett. 2018 May 1;421:145-151. doi: 10.1016/j.canlet.2018.02.026. Epub 2018 Feb 20.


HuR, TTP, and miR-133b expression in NSCLC and their association with prognosis.

Qian L, Ji AH, Zhang WJ, Zhao N.

Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):430-442. doi: 10.26355/eurrev_201801_14192.


Hu antigen R (HuR) heterogeneous expression quantification as a prognostic marker of melanoma.

Liaudet N, Fernandez M, Fontao L, Kaya G, Merat R.

J Cutan Pathol. 2018 May;45(5):333-336. doi: 10.1111/cup.13119. Epub 2018 Feb 23.


Over-expression of oncigenic pesudogene DUXAP10 promotes cell proliferation and invasion by regulating LATS1 and β-catenin in gastric cancer.

Xu Y, Yu X, Wei C, Nie F, Huang M, Sun M.

J Exp Clin Cancer Res. 2018 Jan 27;37(1):13. doi: 10.1186/s13046-018-0684-8.


Functional Role of a Novel Long Noncoding RNA TTN-AS1 in Esophageal Squamous Cell Carcinoma Progression and Metastasis.

Lin C, Zhang S, Wang Y, Wang Y, Nice E, Guo C, Zhang E, Yu L, Li M, Liu C, Hu L, Hao J, Qi W, Xu H.

Clin Cancer Res. 2018 Jan 15;24(2):486-498. doi: 10.1158/1078-0432.CCR-17-1851. Epub 2017 Nov 3.


Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma.

Kresoja-Rakic J, Sulemani M, Kirschner MB, Ronner M, Reid G, Kao S, Schwaller B, Weder W, Stahel RA, Felley-Bosco E.

Front Genet. 2017 May 29;8:70. doi: 10.3389/fgene.2017.00070. eCollection 2017.


Cytoplasmic overexpression of RNA-binding protein HuR is a marker of poor prognosis in meningioma, and HuR knockdown decreases meningioma cell growth and resistance to hypoxia.

Gauchotte G, Hergalant S, Vigouroux C, Casse JM, Houlgatte R, Kaoma T, Helle D, Brochin L, Rech F, Peyre M, Labrousse F, Vallar L, Guéant JL, Vignaud JM, Battaglia-Hsu SF.

J Pathol. 2017 Aug;242(4):421-434. doi: 10.1002/path.4916. Epub 2017 Jul 5.


Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities.

Su SC, Lin CW, Liu YF, Fan WL, Chen MK, Yu CP, Yang WE, Su CW, Chuang CY, Li WH, Chung WH, Yang SF.

Theranostics. 2017 Feb 26;7(5):1088-1099. doi: 10.7150/thno.18551. eCollection 2017.


Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer.

Melling N, Taskin B, Hube-Magg C, Kluth M, Minner S, Koop C, Grob T, Graefen M, Heinzer H, Tsourlakis MC, Izbicki J, Wittmer C, Huland H, Simon R, Wilczak W, Sauter G, Steurer S, Schlomm T, Krech T.

Prostate. 2016 Feb 15;76(3):259-72. doi: 10.1002/pros.23120. Epub 2015 Nov 2.


HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival.

Davidson B, Holth A, Hellesylt E, Hadar R, Katz B, Tropé CG, Reich R.

Hum Pathol. 2016 Feb;48:95-101. doi: 10.1016/j.humpath.2015.09.027. Epub 2015 Oct 22.


Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.

Elebro J, Ben Dror L, Heby M, Nodin B, Jirström K, Eberhard J.

Acta Oncol. 2016;55(3):286-96. doi: 10.3109/0284186X.2015.1075663. Epub 2015 Sep 11.


Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer.

Prislei S, Martinelli E, Zannoni GF, Petrillo M, Filippetti F, Mariani M, Mozzetti S, Raspaglio G, Scambia G, Ferlini C.

Oncotarget. 2015 Aug 7;6(22):18966-79.


Multifaceted roles of HSF1 in cancer.

Jiang S, Tu K, Fu Q, Schmitt DC, Zhou L, Lu N, Zhao Y.

Tumour Biol. 2015 Jul;36(7):4923-31. doi: 10.1007/s13277-015-3674-x. Epub 2015 Jun 25. Review.


Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma.

Vigouroux C, Casse JM, Battaglia-Hsu SF, Brochin L, Luc A, Paris C, Lacomme S, Gueant JL, Vignaud JM, Gauchotte G.

Lung Cancer. 2015 Aug;89(2):189-96. doi: 10.1016/j.lungcan.2015.05.008. Epub 2015 May 16.


Genome-wide analysis of alternative transcripts in human breast cancer.

Wen J, Toomer KH, Chen Z, Cai X.

Breast Cancer Res Treat. 2015 Jun;151(2):295-307. doi: 10.1007/s10549-015-3395-2. Epub 2015 Apr 26.


The role of the small GTPase Rab31 in cancer.

Chua CE, Tang BL.

J Cell Mol Med. 2015 Jan;19(1):1-10. doi: 10.1111/jcmm.12403. Epub 2014 Dec 3. Review.


Control of pro-angiogenic cytokine mRNA half-life in cancer: the role of AU-rich elements and associated proteins.

Griseri P, Pagès G.

J Interferon Cytokine Res. 2014 Apr;34(4):242-54. doi: 10.1089/jir.2013.0140. Review.


Supplemental Content

Loading ...
Support Center